ConductScience.org, home

Paper329

Pneumococcal type-associated variability in alternate complement pathway activation.

Fine DP. Infect Immun, 1975. Cited by 130 papers, by iCite.

11 sourcespapers-2026-11-12-0.1.0

Download JSON
Cite this record

ConductScience Library. Pneumococcal type-associated variability in alternate complement pathway activation. Papers, record 329. Release papers-2026-11-12-0.1.0, 12 Nov 2026. https://conductscience.org/library/papers/329

Paper

PubMed's record of the paper, with iCite's citation figures. No abstract is shown.

Title
Pneumococcal type-associated variability in alternate complement pathway activation.
PubMed
Journal
Infect Immun
PubMed
Year
1975
PubMed
Publication types
Journal Article
PubMed
Citations, by iCite
130
iCite
Relative citation ratio, by iCite
4.15
iCite
Revised in PubMed
2021-05-26
PubMed

Authors1

The authors in the order PubMed's record lists them, with the ORCID iDs it states.

OrderAuthorForenameKindORCID iD
1Fine DPD P

Source PubMed

Topics9

NLM's MeSH indexing of the paper, its major topics first.

MeSH termMajor
Complement System ProteinsMajor topic
Streptococcus pneumoniaeMajor topic
Antigen-Antibody Complex
Complement C3
Edetic Acid
Egtazic Acid
Humans
Serotyping
Zymosan

Source PubMed

References18

The papers the reference list in PubMed's record names, those in our copy of PubMed, in the list's order.

OrderPMIDTitleJournalYearIn PapersSource
214,156,606PNEUMOCOCCAL BACTEREMIA WITH ESPECIAL REFERENCE TO BACTEREMIC PNEUMOCOCCAL PNEUMONIA.Ann Intern Med1964https://conductscience.org/library/papers/14156606PubMed
35,960,883Methods for the separation, purification and measurement of nine components of hemolytic complement in guinea-pig serum.Immunochemistry1966https://conductscience.org/library/papers/5960883PubMed
44,105,810The C3-activator system: an alternate pathway of complement activation.J Exp Med1971https://conductscience.org/library/papers/4105810PubMed
54,144,636Opsonins: their function, identity, and clinical significance.J Pediatr1973https://conductscience.org/library/papers/4144636PubMed
64,150,446The role of immunoglobulin in the interaction of pneumococci and the properdin pathway: evidence for its specificity and lack of requirement for the Fc portion of the molecule.J Immunol1974https://conductscience.org/library/papers/4150446PubMed
74,152,800Capsular types and outcome of bacteremic pneumococcal disease in the antibiotic era.Arch Intern Med1974https://conductscience.org/library/papers/4152800PubMed
84,152,919Influence of the alternate complement pathway in opsonization of several bacterial species.Infect Immun1974https://conductscience.org/library/papers/4152919PubMed
94,208,047Sensitization of E. coli to the serum bactericidal system and to lysozyme by ethyleneglycoltetraacetic acid.Proc Soc Exp Biol Med1974https://conductscience.org/library/papers/4208047PubMed
104,394,495Types of pneumococci found in blood, spinal fluid and pleural exudate during a period of 15 years (1954-1969).Acta Pathol Microbiol Scand B Microbiol Immunol1970https://conductscience.org/library/papers/4394495PubMed
114,402,312Heat labile opsonins to Pneumococcus. 3. The participation of immunoglobulin and of the alternate pathway of C3 activation.J Immunol1972https://conductscience.org/library/papers/4402312PubMed
124,403,402Bactericidal and opsonic properties of C4-deficient guinea pig serum.J Immunol1972https://conductscience.org/library/papers/4403402PubMed
134,604,857Opsonic activity in human serum chelated with ethylene glycoltetra-acetic acid.Immunology1974https://conductscience.org/library/papers/4604857PubMed
144,624,675Human heat labile opsonins: evidence for their mediation via the alternate pathway of complement activation.J Immunol1972https://conductscience.org/library/papers/4624675PubMed
154,627,510C3 shunt activation in human serum chelated with EGTA.J Immunol1972https://conductscience.org/library/papers/4627510PubMed
164,997,584In vitro studies of complement function in sera of C4-deficient guinea pigs.J Exp Med1971https://conductscience.org/library/papers/4997584PubMed
175,005,029Phylogeny and function of the complement system.Annu Rev Microbiol1971https://conductscience.org/library/papers/5005029PubMed
185,470,510Complement and complement-like activity in lower vertebrates and invertebrates.J Exp Med1970https://conductscience.org/library/papers/5470510PubMed
195,543,727Opsonic activity of agammaglobulinemic human sera.J Immunol1971https://conductscience.org/library/papers/5543727PubMed

Cited by44

The papers in our copy of PubMed whose reference list names this one, newest first. iCite, which reads more sources, counts 130 citations.

PMIDTitleJournalYearIn PapersSource
35,258,552Functional vulnerability of liver macrophages to capsules defines virulence of blood-borne bacteria.J Exp Med2022https://conductscience.org/library/papers/35258552PubMed
30,873,934Streptococcus pneumoniae: Invasion and Inflammation.Microbiol Spectr2019https://conductscience.org/library/papers/30873934PubMed
26,244,863A Three-Tiered Study of Differences in Murine Intrahost Immune Response to Multiple Pneumococcal Strains.PLoS One2015https://conductscience.org/library/papers/26244863PubMed
21,864,623The innate immune response to Streptococcus pneumoniae in the lung depends on serotype and host response.Vaccine2011https://conductscience.org/library/papers/21864623PubMed
21,768,284Two DHH subfamily 1 proteins contribute to pneumococcal virulence and confer protection against pneumococcal disease.Infect Immun2011https://conductscience.org/library/papers/21768284PubMed
19,139,190Role of complement in host defense against pneumococcal otitis media.Infect Immun2009https://conductscience.org/library/papers/19139190PubMed
18,541,650Impaired opsonization with C3b and phagocytosis of Streptococcus pneumoniae in sera from subjects with defects in the classical complement pathway.Infect Immun2008https://conductscience.org/library/papers/18541650PubMed
12,496,169Genetic alteration of capsule type but not PspA type affects accessibility of surface-bound complement and surface antigens of Streptococcus pneumoniae.Infect Immun2003https://conductscience.org/library/papers/12496169PubMed
11,349,040Requirement for capsule in colonization by Streptococcus pneumoniae.Infect Immun2001https://conductscience.org/library/papers/11349040PubMed
11,321,237Lymphocyte subset populations in children with polysaccharide antibody deficiency following cardiac transplantation.J Clin Immunol2001https://conductscience.org/library/papers/11321237PubMed
10,456,894Resistance to both complement activation and phagocytosis in type 3 pneumococci is mediated by the binding of complement regulatory protein factor H.Infect Immun1999https://conductscience.org/library/papers/10456894PubMed
10,417,182Molecular and functional characteristics of a protective human monoclonal antibody to serotype 8 Streptococcus pneumoniae capsular polysaccharide.Infect Immun1999https://conductscience.org/library/papers/10417182PubMed
8,531,887Streptococcus pneumoniae: virulence factors, pathogenesis, and vaccines.Microbiol Rev1995https://conductscience.org/library/papers/8531887PubMed
8,472,245Pathogenesis and pathophysiology of bacterial meningitis.Clin Microbiol Rev1993https://conductscience.org/library/papers/8472245PubMed
8,168,944Effect of genetic switching of capsular type on virulence of Streptococcus pneumoniae.Infect Immun1994https://conductscience.org/library/papers/8168944PubMed
7,429,626Effect of intravenously injected killed pneumococci on leukocytes, complement, and phagocytosis in rabbits.Infect Immun1980https://conductscience.org/library/papers/7429626PubMed
7,361,859Experimental type 25 pneumococcal pneumonia in rats: an electron-microscopic study.Am J Pathol1980https://conductscience.org/library/papers/7361859PubMed
7,263,061Reduction of circulating granulocytes induced by type 1 pneumococcal cell walls in New Zealand white rabbits.Infect Immun1981https://conductscience.org/library/papers/7263061PubMed
7,216,447Evaluation of the opsonic requirements for phagocytosis of Streptococcus pneumoniae serotypes VII, XIV, and XIX by chemiluminescence assay.Infect Immun1981https://conductscience.org/library/papers/7216447PubMed
6,995,341Activation of the alternative pathway of complement by mycobacteria and cord factor.Infect Immun1980https://conductscience.org/library/papers/6995341PubMed

See all 44 cited by

Genes2

The genes the Gene search release ties to the paper: Swiss-Prot's references first, then PubTator's text mining.

GeneNCBI Gene IDLinked byIn GenesSource
C3718PubTator's text mininghttps://conductscience.org/library/genes/718NCBI Gene
COX8A1,351PubTator's text mininghttps://conductscience.org/library/genes/1351NCBI Gene

Data dates

The date of each source this release read.

PubMed
2026-11-06
PubMed
iCite
2026-11-05
iCite
PMC's ID file
2026-11-05
PMC's ID file
NIH RePORTER's grant and paper links
2026-11-01
NIH RePORTER's grant and paper links
Trials
2026-11-12
Gene search
2026-11-11
Pipelines
2026-09-18

None in this release

  • Grants
  • Trials
  • Comments and corrections
  • Drugs
  • Data

Sources 11

  • ChEMBL, through Open TargetsCC BY-SA 3.0
  • ClinicalTrials.govNo license stated
  • HGNCCC0
  • iCiteCC BY 4.0
  • NCBI GenePublic domain (US government)
  • NIH RePORTER's grant and paper linksPublic domain
  • Open TargetsCC0 1.0
  • PMC's ID filePublic domain (US government)
  • PubMedNLM's terms
  • PubTator 3Public domain
  • UniProtCC BY 4.0
Each source's terms
  • ChEMBL, through Open TargetsCC BY-SA 3.0, for the parts from ChEMBL. Read on 8 Nov 2026 at https://platform-docs.opentargets.org/licence
  • ClinicalTrials.govnone stated
  • HGNCCC0: https://www.genenames.org/about/license/
  • iCiteCC BY 4.0
  • NCBI GeneNone named for the file. NCBI says information created by or for the US government on its site is in the public domain, and asks that NLM be acknowledged: https://www.ncbi.nlm.nih.gov/home/about/policies/
  • NIH RePORTER's grant and paper linksPublic domain (NIH RePORTER)
  • Open TargetsCC0 1.0. Open Targets asks that users cite its latest paper: Buniello et al. 2025, Open Targets Platform: facilitating therapeutic hypotheses building in drug discovery, Nucleic Acids Research 53(D1):D1467, PMID 39657122. Read on 8 Nov 2026 at https://platform-docs.opentargets.org/licence
  • PMC's ID fileNone named for the file. NCBI says information created by or for the US government on its site is in the public domain, and asks that NLM be acknowledged: https://www.ncbi.nlm.nih.gov/home/about/policies/
  • PubMedNLM's terms
  • PubTator 3Public domain
  • UniProtCC BY 4.0. UniProt's licence file: "All databases and documents in the UniProt FTP directory may be copied and redistributed freely, without advance permission, provided that this copyright statement is reproduced with each copy." UniProt asks that users cite its latest paper: The UniProt Consortium, UniProt: the Universal Protein Knowledgebase in 2025, Nucleic Acids Research 53:D609-D617, https://doi.org/10.1093/nar/gkae1010. Read on 9 Nov 2026 at https://www.uniprot.org/help/license

ClinicalTrials.gov's data carry an international copyright outside the United States: https://clinicaltrials.gov/about-site/terms-conditions.

For software

Read this paper from software.

The record and each of its lists are JSON, twenty rows a page. No key.

GET https://conductscience.org/api/papers/v1/329

GET https://conductscience.org/api/papers/v1/329/cited_by?page=2